Retzius-Sparing Prostatectomy: Is It the Future of Prostate Cancer Surgery?
"Explore the innovative Retzius-sparing approach in robot-assisted prostatectomy and how it's changing functional outcomes for patients."
Prostate cancer treatment has seen remarkable advancements, especially with the introduction of robotic surgery. These innovations aim not only to eradicate the cancer but also to preserve crucial aspects of life after surgery, such as urinary continence.
One such innovation is the Retzius-sparing robot-assisted radical prostatectomy (RS-RARP). Traditional prostatectomy involves removing the prostate gland along with surrounding tissues, often disrupting the Retzius space—an area critical for bladder support and urinary control. RS-RARP, however, preserves this space, potentially leading to quicker recovery of continence.
This article delves into the RS-RARP technique, comparing it with standard RARP, and explores its benefits, outcomes, and what it might mean for the future of prostate cancer surgery. We'll examine the evidence, consider expert opinions, and provide a clear picture of this evolving surgical approach.
Why Interest Is Growing
Retzius-sparing robotic prostatectomy is a novel approach intended to improve patient-reported outcomes after prostatectomy. Its popularity has increased because it is associated with improved early urinary continence. Research comparing Retzius-sparing and standard techniques is also examining long-term cancer-control outcomes and early urinary continence in patients with clinically localized prostate cancer.
Standard and Retzius-Sparing Techniques
Since robot-assisted radical prostatectomy was introduced in 2001, surgical techniques have continued to emphasize reduced bleeding and improved visualization. The standard approach is anterior, whereas Retzius-sparing robotic-assisted radical prostatectomy approaches the prostate posteriorly through the Pouch of Douglas. This posterior route preserves anterior periurethral support structures that are disrupted during the standard approach.
From Young to Robotic Surgery
Hugh Hampton Young described the first radical perineal prostatectomy in 1905, establishing surgery as a management strategy for men with localized prostate cancer. Before Patrick Walsh introduced his nerve-sparing radical prostatectomy in 1982, patients faced a choice between surgery with risks of incontinence and impotence or treatment that might not completely remove the disease. Radical prostatectomy has continued to evolve through robot-assisted and single-port surgery, with an emphasis on minimizing morbidity while maintaining oncologic safety.
What Is Retzius-Sparing Prostatectomy and How Does It Work?
The Retzius space is located between the pubic bone and the bladder. Traditional prostatectomy often involves disrupting or removing tissues in this area, which can affect urinary control. RS-RARP is designed to avoid this disruption.
- Faster return to urinary continence
- Reduced risk of bladder neck descent
- Minimized distortion of urethral tissues
Recent Functional and Clinical Evidence
A comparative analysis reported that Retzius-sparing robot-assisted radical prostatectomy demonstrated significantly better urinary continence at 12 months than conventional robot-assisted radical prostatectomy, with p < 0.01. The same analysis found a significant difference in sexual function, with p = 0.03. Separately, a retrospective cohort study evaluated 100 patients who underwent Retzius-sparing robotic radical prostatectomy at Clemenceau Medical Center Hospital in Dubai between June 2021 and December 2024.
Unresolved Questions
Whether continence recovery at 12 months is superior after Retzius-sparing surgery remains undetermined according to a systematic review and meta-analysis. Another study reported limited solid evidence on postoperative sexual function and a lack of long-term survival data. A separate meta-analysis also identified the inclusion of non-randomized controlled trials as a limitation. In addition, one report warned that cancer outcomes might be compromised even though early urinary continence recovery may be faster.
Early Continence Advantage
In one comparative study, urinary continence recovery after catheter removal was higher with Retzius-sparing surgery at 1 week, 1 month, 2 months, and 3 months. The reported rates were 91.2% versus 54.3% at 1 week, 92.2% versus 66.7% at 1 month, 95.1% versus 74.3% at 2 months, and 96.1% versus 83.8% at 3 months. At 6 months, the difference was not statistically significant: 97% versus 90.5%, with p = 0.09. The technique uses a posterior route through the Douglas space and was included in European Association of Urology guidelines in 2020 as an alternative to standard robot-assisted radical prostatectomy for localized prostate cancer.
Is Retzius-Sparing Prostatectomy Right for You?
If you or a loved one is facing prostate cancer surgery, understanding the options is crucial. RS-RARP represents a significant advancement, potentially offering a better quality of life after surgery. Discuss this option with your healthcare provider to determine if it's the right approach for your specific situation. As research continues and techniques evolve, RS-RARP may indeed become the future of prostate cancer surgery, balancing effective cancer treatment with improved patient outcomes.
A Promising but Developing Approach
Retzius-sparing robotic prostatectomy is described as a novel approach aimed at improving patient-reported outcomes after prostatectomy. Its growing popularity is associated with improved early urinary continence. These potential functional benefits support continued interest in the technique, while its future role depends on ongoing evaluation of patient outcomes and cancer control.
Applicability Across Patients
A 2024 review reported satisfactory functional results for Retzius-sparing robot-assisted radical prostatectomy irrespective of disease stage and prostate volume. The review also described promising results in patients previously treated for benign prostatic hyperplasia and in the salvage setting. It nevertheless framed optimization of these results as an ongoing question.
Recovery and Quality of Life
Retzius-sparing robot-assisted radical prostatectomy has emerged as an option in high-volume centers, and one study assessed implementation in a medium-volume center without previous robotic-surgery experience. A patient summary reported that the technique improves urinary function and quality of life without compromising cancer control. In an individual case reported by MD Anderson, Alejandro Ayestaran ran a 10K six weeks after surgery following rehabilitation exercises and Retzius-sparing prostatectomy, which limits urinary incontinence.